Letter
Luminal B breast tumors are not HER2 positive
-
* Corresponding author: Rohit Bhargava rbhargava@mail.magee.edu
Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Halket Street, Pittsburgh, Pennsylvania 15213, USA
Breast Cancer Research 2008, 10:404 doi:10.1186/bcr2134
Published: 26 September 2008First paragraph (this article has no abstract)
We read with interest the article by Tamimi and coworkers recently published in this journal [1]. The authors compared the molecular subtypes of invasive carcinoma versus ductal carcinoma in situ and found significant differences, as expected [1]. However, we have some concerns regarding the criteria used in the study.